Elutia Inc. (NASQAG: ELUT) Reducing Surgical Infection Risk & Scaling Commercial Adoption

How Elutia's drug-eluting biomatrix technology is targeting post-surgical infection in implant-based breast reconstruction — and the unmet need driving that mission.

Format

YouTube

Quelle:

Elutia Inc.